Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Marie Virally"'
Autor:
Jean-Olivier Contreres, Yu Wang, Jean-Sébastien Silvestre, Chris S. Mantsounga, Tatiana Merkulova-Rainon, Marie Virally, Pierre-Jean Guillausseau, Jean-Jacques Mourad, Bernard I. Levy, Carole Leré-Déan, David Allanic, Patricia Hainaud, Dong Broqueres-You, José Vilar
Publikováno v:
Diabetes
We hypothesized that in vitro treatment of peripheral blood mononuclear cells (PB-MNCs) from diabetic patients with ephrin-B2/Fc (EFNB2) improves their proangiogenic therapeutic potential in diabetic ischemic experimental models. Diabetes was induced
Autor:
T. Meas, Jean-Philippe Kevorkian, Marie Virally, C. Ambonville, Marie Laloi-Michelin, Pierre-Jean Guillausseau
Publikováno v:
La Revue de Médecine Interne. 31:216-221
Mitochondrial diabetes affects up to 1% of patients with diabetes and is often unrecognised by the physicians. Maternally inherited diabetes and deafness (MIDD) resulting from the mutation 3243A>G of the mitochondrial DNA is the most frequent mutatio
Autor:
Pierre-Jean Guillausseau, H. Mosnier-Pudar, G. Hochberg, O. Pexoto, Marie Virally, Serge Halimi, Sylvie Dejager, E. Eschwège
Publikováno v:
Médecine des Maladies Métaboliques. 3:620-623
Les objectifs de l’enquete Diabasis etaient de decrire la perception et le vecu du diabete de type 2 (DT2) par les patients diabetiques eux-memes. Pres de 20 000 questionnaires ont ete envoyes par courrier dans la population generale ; 14 201 ont e
Autor:
E. Eschwège, G. Hochberg, H. Mosnier-Pudar, Sylvie Dejager, Pierre-Jean Guillausseau, Marie Virally, Serge Halimi, O. Pexoto
Publikováno v:
Médecine des Maladies Métaboliques. 3:538-543
Les objectifs de l’enquete Diabasis etaient de decrire la perception du diabete de type 2 (DT2) dans un echantillon representatif de la population francaise âgee de 45 ans et plus. Pres de 20 000 questionnaires ont ete envoyes par courrier dans la
Autor:
Marie Laloi-Michelin, J. Cahen-Varsaux, J.-F. Blickle, B Delemer, J. Mausset, A. Sola-Gazagnes, Eric Bertin, S. Schneebeli, Sandrine Beaufils, D. Paris-Bockel, T. Crea, Lise Bernard, Bernard Vialettes, T. Gabreau, A. Cailleba, J. L. Thomas, F. Olivier, Jean-Pierre Riveline, Jacques Louis, Danièle Dubois-Laforgue, Pierre-Henri Ducluzeau, C. Ambonville, P. Cathebras, S. Casanova, Béatrice Bouhanick, F. Lorenzini, Pascale Massin, S. Nadler-Fluteau, José Timsit, Guillaume Charpentier, P. Chedin, H. Gin, A. Murat, Yves Reznik, E. Larger, A. Grimaldi, T. Meas, Pierre-Jean Guillausseau, Bernard Bauduceau, Bruno Guerci, L. Dusselier, B. Trabulsi, E. Sonnet, I. Raynaud, F. Duchemin, V. Jacquin, C. Bellanné-Chantelot, A. Lecleire-Collet, E. Kaloustian, Véronique Paquis-Flucklinger, Marie Virally
Publikováno v:
The Journal of clinical endocrinology & metabolism
The Journal of clinical endocrinology & metabolism, 2009, 94 (8), pp.3025-3030. ⟨10.1210/jc.2008-2680⟩
The Journal of clinical endocrinology & metabolism, 2009, 94 (8), pp.3025-3030. ⟨10.1210/jc.2008-2680⟩
International audience; Context: Maternally inherited diabetes and deafness (MIDD) is a rare form of diabetes with a matrilineal transmission, sensorineural hearing loss, and macular pattern dystrophy due to an A to G transition at position 3243 of m
Autor:
Jean-Philippe Kevorkian, J. Peynet, T. Meas, Marie Virally, Marie Laloi-Michelin, V. Giraudeaux, Pierre-Jean Guillausseau
Publikováno v:
European Journal of Internal Medicine. 20:197-200
Interest of statins in terms of morbid-mortality reduction in primary and secondary prevention in type 2 diabetic patients has broadly been proven in recent studies, while evidence for fibrates preventive effect is considerably weaker. HMGCoA reducta
Autor:
Jean-Philippe Kevorkian, Pierre-Jean Guillausseau, Marie Laloi-Michelin, Taly Meas, Marie Virally, Catherine Ambonville, Julie Bitu
Publikováno v:
Sang thrombose vaisseaux. 21:015-022
Les resultats de trois etudes, ADVANCE, VA Diabetes Trial (VA DT) et ACCORD, destinees a evaluer l’effet d’un controle glycemique intensif sur le developpement et la progression des complications micro- et macrovasculaires du diabete de type 2 (D
Autor:
T. Meas, Jean-Philippe Kevorkian, Marie Laloi-Michelin, J. Bitu, C. Ambonville, Pierre-Jean Guillausseau, Marie Virally
Publikováno v:
Médecine des Maladies Métaboliques. 2:S137-S141
Resume Le diabete de type 2, maladie multifactorielle, est lie a l’association d’un deficit de l’insulinosensibilite ou insulinoresistance liee aux habitudes de vie (acquise) et d’un deficit de l’insulinosecretion (inne). Aux stades de debu
Autor:
J.B. Truc, N. Ciraru, N. Ouled, V. Médeau, Jean-Philippe Kevorkian, Marie Virally, T. Meas, P.J. Guillausseau, Marie Laloi-Michelin
Publikováno v:
Diabetes & Metabolism. 33:290-295
Aim Among the numerous guidelines defining the diagnostic strategy of gestational diabetes mellitus (GDM), none of them suggest a follow-up in women with risk factors beyond the 28th week of gestation (WG). The primary objective of this study was to
Autor:
Muriel Coupaye, Marie Laloi-Michelin, T. Meas, Pierre-Jean Guillausseau, Amélie Tielmans, Marie Virally
Publikováno v:
La Presse Médicale. 36:467-474
Insulin secretagogues and insulin sensitizers can be combined with one another as well as with other treatments (described below). Alpha-glucosidase inhibitors delay intestinal absorption of carbohydrates and reduce postprandial glycemia. Orlistat an